Alona Kuzmina
Overview
Explore the profile of Alona Kuzmina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tfilin Samuel M, Rostovsky I, Kuzmina A, Taube R, Sal-Man N
Gut Microbes
. 2025 Mar;
17(1):2474146.
PMID: 40032826
In recent years, various strategies have been developed to enable the oral administration of protein-based drugs (biologics) with the aim of overcoming the degradation and inactivation of these drugs that...
2.
Rostovsky I, Wieler U, Kuzmina A, Taube R, Sal-Man N
Microb Cell Fact
. 2024 Jun;
23(1):163.
PMID: 38824527
Background: Type I interferons (IFN-I)-a group of cytokines with immunomodulatory, antiproliferative, and antiviral properties-are widely used as therapeutics for various cancers and viral diseases. Since IFNs are proteins, they are...
3.
Kuzmina A, Sadhu L, Hasanuzzaman M, Fujinaga K, Schwartz J, Fackler O, et al.
PLoS Pathog
. 2024 Apr;
20(4):e1012172.
PMID: 38662769
The implementation of antiretroviral therapy (ART) has effectively restricted the transmission of Human Immunodeficiency Virus (HIV) and improved overall clinical outcomes. However, a complete cure for HIV remains out of...
4.
Sevilya Z, Kuzmina A, Cipok M, Hershkovitz V, Keidar-Friedman D, Taube R, et al.
J Thromb Thrombolysis
. 2023 Sep;
56(4):538-547.
PMID: 37736784
COVID-19 disease is associated with an increased risk of thrombotic complications, which contribute to high short-term mortality. Patients with COVID-19 demonstrate enhanced platelet turnover and reactivity, which may have a...
5.
Hertz T, Levy S, Ostrovsky D, Oppenheimer H, Zismanov S, Kuzmina A, et al.
Nat Commun
. 2023 Jul;
14(1):4575.
PMID: 37516771
Vaccination, especially with multiple doses, provides substantial population-level protection against COVID-19, but emerging variants of concern (VOC) and waning immunity represent significant risks at the individual level. Here we identify...
6.
Kuzmina A, Korovin D, Cohen Lass I, Atari N, Ottolenghi A, Hu P, et al.
Heliyon
. 2023 Jun;
9(6):e16750.
PMID: 37292300
The rapid spread and dominance of the Omicron SARS-CoV-2 lineages have posed severe health challenges worldwide. While extensive research on the role of the Receptor Binding Domain (RBD) in promoting...
7.
Kuzmina A, Wattad S, Engel S, Rosenberg E, Taube R
Viruses
. 2022 Apr;
14(4).
PMID: 35458533
Enhanced viral transmission and escape from vaccine-elicited neutralizing antibodies drive worldwide spread of SARS-CoV-2 variants and promote disease progression. However, the impact of specific spike mutations that are carried by...
8.
Kuzmina A, Wattad S, Khalaila Y, Ottolenghi A, Rosental B, Engel S, et al.
iScience
. 2021 Nov;
24(12):103467.
PMID: 34805783
Since their identification, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Kappa and Delta have rapidly spread to become globally dominant. However, their infectivity and sensitivity to administered vaccines have not...
9.
Kuzmina A, Khalaila Y, Voloshin O, Keren-Naus A, Boehm-Cohen L, Raviv Y, et al.
Cell Host Microbe
. 2021 Mar;
29(4):522-528.e2.
PMID: 33789085
Toward eradicating the COVID-19 pandemic, vaccines that induce high humoral and cellular immune responses are essential. However, SARS-CoV-2 variants have begun to emerge and raise concerns, as they may potentially...
10.
Krasnopolsky S, Novikov A, Kuzmina A, Taube R
Biochim Biophys Acta Gene Regul Mech
. 2020 Dec;
1864(1):194656.
PMID: 33333262
Pivotal studies on the control of HIV transcription has laid the foundations for our understanding of how metazoan transcription is executed, and what are the factors that control this step....